Evidence-Based Medicine
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17448-17455
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17448
Table 4 Pathologic examination results
VariablesGroup 1Group 2P value
(n = 46)(n = 32)
Tumor size (cm)3 (1.0-8.0)3 (1.6-6.0)0.315
Lymph node metastases0.299
No21 (45.7)12 (37.5)
< 522 (47.8)15 (46.9)
5-102 (4.3)5 (15.6)
> 101 (2.2)0 (0.0)
Pancreaticojejunostomy construction method0.613
Dunking or other4 (12.5)3 (6.5)
Duct to mucosa28 (87.5)43 (93.5)
R0 resection35 (75.6)25 (78.1)0.793
R1 resection11 (24.4)7 (21.9)
AJCC staging (7th edition)0.981
Stage IA2 (4.3)2 (6.3)
Stage IB4 (8.7)3 (9.4)
Stage IIA14 (30.4)8 (25.0)
Stage IIB25 (54.3)18 (56.3)
Stage III1 (2.2)1 (3.1)
Stage IA/IB/IIA (no lymph node involvement)20 (43.5)13 (40.6)0.802
Stage IIB/III (advanced)26 (56.5)19 (59.4)